Address

Atlas Venture
25 First Street
Suite 303
Cambridge, MA 2141
United States

Open map


Recent investment activity

KANDO id: 24121

Corporate information

Registration country

Funding rounds

Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 115
Profile Country Date Funding
Adnexus Therapeutics Inc A biotechnology company focused on developing new class of therapeutic compounds. N/A
Alnylam Pharmaceuticals Inc N/A
Avila Therapeutics Inc A biotechnology company, pioneering a method to discover and develop new small-molecule medicines that achieve 'protein silencing'. Series A USD 21,000,000 (USD 21,000,000)
Bicycle Therapeutics Ltd A biotechnology company developing a novel technology platform for the creation of a new generation of biotherapeutics. Seed
Castle Networks Inc N/A
CloudSwitch Inc Provides an innovative software appliance that empowers an enterprise. Series A USD 7,400,000 (USD 7,400,000)
CytoMed Inc A biotechnology company, engages in the discovery, development, and commercialization of pharmaceuticals to treat inflammation. N/A
Dailymotion SA A web video portal for members to see, create, and share online videos. Series A USD 9,500,000 (USD 9,500,000)
DataPower Technology Inc N/A
DataXu Inc Provider of the leading real-time media management platform for digital advertising campaigns across online, mobile and video channels. Series A USD 7,800,000 (USD 7,800,000)
DisplayLink Corp Developer of USB graphics technology designed to connect computers and displays using USB and Wireless USB. Series D USD 15,000,000 (USD 15,000,000)
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. N/A
eDial Inc Conferencing and collaboration software company for enterprises and service providers. N/A
Egalet Ltd A specialty pharma company focusing on pain management. N/A USD 27,600,000 (USD 27,600,000)
EnglishCentral Inc A web-based English language learning startup company. Seed USD 1,380,000 (USD 1,380,000)
f-star Biotechnologische Forschungs- und Entwicklungsges mbH (f-star), (f-star Biotech) A next generation antibody company developing improved therapeutic antibodies and antibody fragments based on its unique Modular Antibody Technology. Seed USD 1,950,000 (USD 1,950,000)
Fireclick Inc Provider of web analytics solutions. N/A
FirstSense Software Inc Application management software company that could identify the root cause of application performance issues. N/A
Fundraise.com Inc Seed
FutureTense Inc N/A

Financials